All Press Releases for February 18, 2020

Indu Parikh Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. Parikh has been endorsed by Marquis Who's Who as a leader in the fields of biomedical science and pharmaceutical research and Deevelopment

Dr. Indu Parikh holds over 35 U.S. patents, as well as well over 200 international patents in his field.

    CHAPEL HILL, NC, February 18, 2020 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Indu Parikh with the Albert Nelson Marquis Lifetime Achievement Award. A highly accomplished scientist, Dr. Parikh celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process for the Award.

Recently retired from his position as a biomedical scientist and pharmaceutical executive, Dr. Parikh accrued over 50 years of expertise in a variety of areas including endocrinology, osteoporosis, mucus hypersecretory and other pulmonary diseases, controlled delivery systems, and proteins and peptides as therapeutic agents. Until recently affiliated with BioMarck Pharmaceuticals, Ltd., where he served as the chief scientific officer, founding chief executive officer, president, and member of the Board of Directors, he brought with him extensive expertise in drug discovery and development in numerous therapeutic, fundraising and licensing areas. While at BioMarck, he was awarded various SBIR grants amounting to more than $7 million. BioMarck is notably a clinical stage biopharmaceutical company with a patented technology platform that boasts a worldwide patented therapeutic platform of over 100 peptide drugs that inhibit the phosphorylation of the MARCKS protein. The company is located in Research Triangle Park, North Carolina. One of his lead compounds, BIO-11006 is in clinical trials in non-small cell lung cancer (NSCLC) and ARDS.

Among other leading roles, as a serial entrepreneur, he was the founder and vice president of R&D of Research Triangle Pharmaceuticals, Ltd. and its Canadian subsidiary, RTP Pharma Inc., a nanotechnology-based drug delivery company. Notably, Waratah Pharmaceuticals, a spin-off RTP Pharma issued an IPO with Canadian Small Cap (CDNX). RTP Pharma was later acquired by SkyePharma in 2002. Prior to that, Dr. Parikh played a major role in establishing the multinational company, Glaxo's R&D operation from ground up; expanding the R&D operation from initial three employees to about 450 over five years. He served as director of biochemistry and biotechnology and director of extramural research at Glaxo Inc. Prior to joining Glaxo, Dr. Parikh was director of Molecular Biology Division at Burroughs Wellcome Company. Prior to his industrial position, Dr. Parikh worked in academia as an assistant professor of pharmacology and assistant professor of medicine at Johns Hopkins University School of Medicine at Baltimore, Maryland.

Renowned for his work, Dr. Parikh was the first to discover, during early '70s, a high potency peptide-based drug which inhibited conversion of angiotensinogen to angiotensin I by the enzyme renin. This work led others to ACE inhibitors which, inhibited conversion of angiotensin I to angiotensin II. Followed by this, he discovered and patented a compound which, effectively inhibited diarrhea caused by cholera infection in animal model. During late '70s, he patented a monoclonal antibody based homogeneous assay for estrogen receptor (ER) useful for breast cancer diagnostic purpose. More recently, he discovered a peptide drug called BIO-11006, which is undergoing clinical trials for COPD, non-small cell lung cancer (NSCLC), and acute respiratory distress syndrome (ARDS). As a seasoned scientist, Dr. Parikh holds over 35 U.S. patents, as well as well over 200 international patents in his field.

Throughout his career, Dr. Parikh has been honored to serve on numerous science advisory and corporate boards for over 12 different biotechnology companies. He has also served as the executive vice president and on the board directors of the Alopecia Areata Research Foundation between 1983 and 1990, a voluntary health organization and primary source of funding for research on basic hair biology and alopecia. Widely published, Dr. Parikh has contributed over 75 articles to scientific publications, has served on the editorial board for three different scholarly journals and co-edited the 1983 book "Affinity Chromatography and Biological Recognition." He has also made more than 70 presentations at various national and international scientific conventions.

Born in Gujarat, India, Dr. Parikh did his under graduate and graduate education at the University of Zurich, Zurich, Switzerland where he was awarded a Doctor of Philosophy in biological chemistry in 1965. Aligned with several industry-related and scientific organizations, he cofounded and served on the governing council of the International Society for Biorecognition Technology from 1984 to 1990. Dr. Parikh is an honorary life member of the Society of Biological Chemistry of India and an honorary member of the National Academy of Sciences in India. Other current and past memberships to his credit include the American Society of Pharmacology and Experimental Therapeutics, the American Society of Biochemistry and Molecular Biology, the American Association of Pharmaceutical Scientists, the Control Release Society, American Thoracic Society, American Society of Clinical Oncology, and National Institutes of Health Alumni Association.

Dr. Parikh, after completing his post-doctoral fellowship at the Weizmann Institute of Science in Israel, was awarded a Visiting Scientist position at the National Institutes of Health, Bethesda, Maryland where he worked with Dr. Christian B. Anfinsen, who was later awarded the Nobel Prize in Chemistry in 1972. At various stages of his professional career, Dr. Parikh secured research grants from the National Institutes of Health and the U.S. Army Medical Command (1970 and 1975) and secured several Small Business Innovation Research grants between 1992 and 1994 and again between 2004 and 2018. A celebrated Marquis listee, Dr. Parikh has been included in Who's Who in Science and Engineering, Who's Who in the World and Who's Who in Finance and Industry.

About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: